50
Participants
Start Date
January 6, 2020
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Active tDCS
active D.C. transcranial stimulation (delivers a low current (1 to 2 mA)) for 10 to 30 minutes, during 5 sessions
Placebo tDCS
inactive DC transcranial stimulation (delivering a non-significant current at the beginning and end of the stimulation, simulating active stimulation) for 10 to 30 minutes, during 5 sessions
Questionnaires
"* visual analogue scale (VAS)~* impulsivity scale: Barratt Impulsiveness Scale - version 11 (BIS-11)~* Decision-making scales: Iowa Gambling Task (IGT) and Balloon Analogue Risk Task (BART)~* Go-No go test~* HAM-D scale~* SF-12 quality of life scale"
RECRUITING
CHU de DIJON, Dijon
Centre Hospitalier Universitaire Dijon
OTHER